Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Prostate Cancer and Prostatic Diseases
|
August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance
Annika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 3, 2025
Artificial Intelligence (AI)-Driven Screening of Equivocal Prostate Immunohistochemistry (IHC) Cases: Development and Validation of a Screening and Cancer Detection Framework
Ramin Nateghi, Ruoji Zhou, Madeline Saft, et al.
Prostate Cancer and Prostatic Diseases
|
December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
Hyung L Kim, Ping Li, Huei-Chung Huang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
European Urology
|
April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA
|
March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
JAMA Network Open
|
July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
JAMA Network Open
|
December 13, 2021
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
Michael Xiang, Ting Martin Ma, Ricky Savjani, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Prostate Cancer and Prostatic Diseases
|
August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance
Annika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 3, 2025
Artificial Intelligence (AI)-Driven Screening of Equivocal Prostate Immunohistochemistry (IHC) Cases: Development and Validation of a Screening and Cancer Detection Framework
Ramin Nateghi, Ruoji Zhou, Madeline Saft, et al.
Prostate Cancer and Prostatic Diseases
|
December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
Hyung L Kim, Ping Li, Huei-Chung Huang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
European Urology
|
April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA
|
March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
JAMA Network Open
|
July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
JAMA Network Open
|
December 13, 2021
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
Michael Xiang, Ting Martin Ma, Ricky Savjani, et al.
Page
of 10